Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation

For locally advanced (T3-4/N+M0) rectal cancer (LARC), neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision (TME) is the standard treatment. It was demonstrated to decrease the local recurrence rate and increase the tumor response grade. However, the distant metastasis remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yaqi, Shen, Lijun, Wan, Juefeng, Zhang, Hui, Wu, Ruiyan, Wang, Jingwen, Wang, Yan, Xu, Ye, Cai, Sanjun, Zhang, Zhen, Xia, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772444/
https://www.ncbi.nlm.nih.gov/pubmed/36569918
http://dx.doi.org/10.3389/fimmu.2022.1067036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772444/
https://www.ncbi.nlm.nih.gov/pubmed/36569918
http://dx.doi.org/10.3389/fimmu.2022.1067036

Ejemplares similares